Annual CAPEX:
$119.16M+$51.28M(+75.55%)Summary
- As of today, PCVX annual capital expenditures is $119.16 million, with the most recent change of +$51.28 million (+75.55%) on December 31, 2024.
- During the last 3 years, PCVX annual CAPEX has risen by +$112.60 million (+1717.83%).
- PCVX annual CAPEX is now at all-time high.
Performance
PCVX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$12.05M+$2.29M(+23.49%)Summary
- As of today, PCVX quarterly capital expenditures is $12.05 million, with the most recent change of +$2.29 million (+23.49%) on September 30, 2025.
- Over the past year, PCVX quarterly CAPEX has dropped by -$26.03 million (-68.37%).
- PCVX quarterly CAPEX is now -78.89% below its all-time high of $57.07 million, reached on December 31, 2023.
Performance
PCVX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$78.58M-$26.03M(-24.89%)Summary
- As of today, PCVX TTM capital expenditures is $78.58 million, with the most recent change of -$26.03 million (-24.89%) on September 30, 2025.
- Over the past year, PCVX TTM CAPEX has dropped by -$67.62 million (-46.25%).
- PCVX TTM CAPEX is now -46.25% below its all-time high of $146.20 million, reached on September 30, 2024.
Performance
PCVX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PCVX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +75.5% | -68.4% | -46.3% |
| 3Y3 Years | +1717.8% | +1328.9% | +1191.8% |
| 5Y5 Years | +9871.5% | +10000.0% | +5569.5% |
PCVX CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1937.6% | -78.9% | +1328.9% | -46.3% | +1243.7% |
| 5Y | 5-Year | at high | >+9999.0% | -78.9% | >+9999.0% | -46.3% | +6703.4% |
| All-Time | All-Time | at high | >+9999.0% | -78.9% | >+9999.0% | -46.3% | >+9999.0% |
PCVX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $12.05M(+23.5%) | $78.58M(-24.9%) |
| Jun 2025 | - | $9.76M(-63.5%) | $104.61M(-25.4%) |
| Mar 2025 | - | $26.75M(-10.9%) | $140.23M(+17.7%) |
| Dec 2024 | $119.16M(+75.6%) | $30.03M(-21.1%) | $119.16M(-18.5%) |
| Sep 2024 | - | $38.08M(-16.1%) | $146.20M(+26.6%) |
| Jun 2024 | - | $45.37M(+699.1%) | $115.46M(+59.9%) |
| Mar 2024 | - | $5.68M(-90.1%) | $72.23M(+0.1%) |
| Dec 2023 | $67.88M(+1060.7%) | $57.07M(+677.6%) | $72.16M(+344.5%) |
| Sep 2023 | - | $7.34M(+242.9%) | $16.23M(+66.7%) |
| Jun 2023 | - | $2.14M(-61.8%) | $9.74M(+14.1%) |
| Mar 2023 | - | $5.61M(+389.0%) | $8.54M(+46.0%) |
| Dec 2022 | $5.85M | $1.15M(+36.1%) | $5.85M(-3.9%) |
| Sep 2022 | - | $843.00K(-10.1%) | $6.08M(-12.6%) |
| Jun 2022 | - | $938.00K(-67.9%) | $6.96M(-15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $2.92M(+111.3%) | $8.23M(+25.5%) |
| Dec 2021 | $6.55M(+467.5%) | $1.38M(-19.6%) | $6.55M(+11.2%) |
| Sep 2021 | - | $1.72M(-22.1%) | $5.89M(+40.2%) |
| Jun 2021 | - | $2.21M(+77.2%) | $4.21M(+104.9%) |
| Mar 2021 | - | $1.25M(+72.6%) | $2.05M(+77.7%) |
| Dec 2020 | $1.16M(-3.3%) | $722.00K(+2389.7%) | $1.16M(-16.7%) |
| Sep 2020 | - | $29.00K(-47.3%) | $1.39M(-2.2%) |
| Jun 2020 | - | $55.00K(-84.2%) | $1.42M(-7.3%) |
| Mar 2020 | - | $349.00K(-63.4%) | $1.53M(+27.9%) |
| Dec 2019 | $1.20M(-32.6%) | $953.00K(+1488.3%) | $1.20M(+393.8%) |
| Sep 2019 | - | $60.00K(-63.9%) | $242.00K(+33.0%) |
| Jun 2019 | - | $166.00K(+937.5%) | $182.00K(+1037.5%) |
| Mar 2019 | - | $16.00K | $16.00K |
| Dec 2018 | $1.77M | - | - |
FAQ
- What is Vaxcyte, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual CAPEX year-on-year change?
- What is Vaxcyte, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly CAPEX year-on-year change?
- What is Vaxcyte, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. TTM CAPEX year-on-year change?
What is Vaxcyte, Inc. annual capital expenditures?
The current annual CAPEX of PCVX is $119.16M
What is the all-time high annual CAPEX for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual capital expenditures is $119.16M
What is Vaxcyte, Inc. annual CAPEX year-on-year change?
Over the past year, PCVX annual capital expenditures has changed by +$51.28M (+75.55%)
What is Vaxcyte, Inc. quarterly capital expenditures?
The current quarterly CAPEX of PCVX is $12.05M
What is the all-time high quarterly CAPEX for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly capital expenditures is $57.07M
What is Vaxcyte, Inc. quarterly CAPEX year-on-year change?
Over the past year, PCVX quarterly capital expenditures has changed by -$26.03M (-68.37%)
What is Vaxcyte, Inc. TTM capital expenditures?
The current TTM CAPEX of PCVX is $78.58M
What is the all-time high TTM CAPEX for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high TTM capital expenditures is $146.20M
What is Vaxcyte, Inc. TTM CAPEX year-on-year change?
Over the past year, PCVX TTM capital expenditures has changed by -$67.62M (-46.25%)